CHC Healthcare Group (TPE:4164)
Taiwan · Delayed Price · Currency is TWD 33.45
+0.45 (1.36%)
Feb 11, 2026, 1:30 PM CST
CHC Healthcare Group Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 4,210 | 3,601 | 3,877 | 2,974 | 2,440 | 2,555 | |
Revenue Growth (YoY) | 4.42% | -7.13% | 30.35% | 21.92% | -4.52% | -13.39% |
Cost of Revenue | 3,228 | 2,841 | 2,809 | 2,072 | 1,590 | 1,724 |
Gross Profit | 982.33 | 759.13 | 1,068 | 902.31 | 849.48 | 830.71 |
Selling, General & Admin | 690.54 | 522.46 | 454.41 | 422.4 | 355.84 | 310.46 |
Research & Development | - | - | - | - | - | 6.25 |
Operating Expenses | 696.88 | 520.42 | 454.68 | 426.55 | 356.15 | 317.61 |
Operating Income | 285.46 | 238.71 | 613.48 | 475.76 | 493.33 | 513.1 |
Interest Expense | -103.46 | -87.58 | -77.34 | -58.89 | -50.18 | -65.43 |
Interest & Investment Income | 20.52 | 26.86 | 22.25 | 16.04 | 11.01 | 13.06 |
Earnings From Equity Investments | -3.77 | 1 | 1.6 | -0.33 | 8.64 | -0.28 |
Currency Exchange Gain (Loss) | 20.31 | 7.59 | -5.34 | 19.69 | 1.77 | -17.25 |
Other Non Operating Income (Expenses) | 44.6 | 37.28 | -7.14 | -6.24 | -4.16 | 21.48 |
EBT Excluding Unusual Items | 263.65 | 223.86 | 547.51 | 446.02 | 460.4 | 464.68 |
Gain (Loss) on Sale of Investments | -4.65 | 4.03 | 13.09 | -17.99 | -0.96 | - |
Gain (Loss) on Sale of Assets | 1.97 | 2.09 | -1.33 | 55.81 | 31.5 | -0.69 |
Other Unusual Items | -7.3 | -6.97 | 0.16 | - | 0.13 | 0.01 |
Pretax Income | 253.67 | 223.01 | 559.43 | 483.84 | 491.07 | 464 |
Income Tax Expense | 71.47 | 40.43 | 134.19 | 95.19 | 110.79 | 101.08 |
Earnings From Continuing Operations | 182.2 | 182.58 | 425.24 | 388.65 | 380.28 | 362.91 |
Minority Interest in Earnings | -20.78 | -14.19 | -6.37 | -32.08 | 1.35 | 3.48 |
Net Income | 161.42 | 168.38 | 418.87 | 356.57 | 381.63 | 366.39 |
Net Income to Common | 161.42 | 168.38 | 418.87 | 356.57 | 381.63 | 366.39 |
Net Income Growth | -50.19% | -59.80% | 17.47% | -6.57% | 4.16% | -7.28% |
Shares Outstanding (Basic) | 179 | 167 | 164 | 161 | 157 | 145 |
Shares Outstanding (Diluted) | 186 | 195 | 194 | 192 | 186 | 201 |
Shares Change (YoY) | -4.43% | 0.55% | 0.92% | 3.31% | -7.82% | 18.56% |
EPS (Basic) | 0.90 | 1.01 | 2.55 | 2.21 | 2.43 | 2.53 |
EPS (Diluted) | 0.90 | 0.98 | 2.26 | 1.98 | 2.18 | 1.95 |
EPS Growth | -49.55% | -56.59% | 14.30% | -9.38% | 11.66% | -20.57% |
Free Cash Flow | 60.86 | -331.72 | 412.92 | -25.97 | 178.7 | 194.77 |
Free Cash Flow Per Share | 0.33 | -1.70 | 2.13 | -0.14 | 0.96 | 0.97 |
Dividend Per Share | 1.510 | 1.510 | 2.010 | 1.968 | 2.011 | 2.010 |
Dividend Growth | -24.88% | -24.88% | 2.11% | -2.12% | 0.05% | 0.50% |
Gross Margin | 23.33% | 21.08% | 27.55% | 30.34% | 34.82% | 32.51% |
Operating Margin | 6.78% | 6.63% | 15.82% | 16.00% | 20.22% | 20.08% |
Profit Margin | 3.83% | 4.68% | 10.80% | 11.99% | 15.64% | 14.34% |
Free Cash Flow Margin | 1.45% | -9.21% | 10.65% | -0.87% | 7.32% | 7.62% |
EBITDA | 892.12 | 847.67 | 1,187 | 959.56 | 941.04 | 943.38 |
EBITDA Margin | 21.19% | 23.54% | 30.63% | 32.26% | 38.57% | 36.92% |
D&A For EBITDA | 606.66 | 608.96 | 573.89 | 483.8 | 447.71 | 430.28 |
EBIT | 285.46 | 238.71 | 613.48 | 475.76 | 493.33 | 513.1 |
EBIT Margin | 6.78% | 6.63% | 15.82% | 16.00% | 20.22% | 20.08% |
Effective Tax Rate | 28.18% | 18.13% | 23.99% | 19.67% | 22.56% | 21.79% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.